Press Release European Medicines Agency gives guidance for use of antiviral medicines in case of a novel influenza A/H1N1 pandemic

The European Medicines Agency (EMEA), on 8 May 2009, gave guidance on the use of Tamiflu (Oseltamivir) in children under one year of age and the use of Tamiflu and Releza (Zanamivir) in pregnant and breastfeeding women in the case of a declared influenza A/H1N1 pandemic.